Åge has more than 35 years of experience in the pharmaceutical industry. He has been an industry leader for over 20 years. Åge has been a board member of the Norwegian Association of Pharmaceutical Manufacturers for more than 10 years. Former positions include General Manager of GSK Norway.
Christian brings more than 20 years experience from international operations., managing R&D and engineering teams in Europe, UAE and India. He started his career in management consulting in the UK, followed by management positions in Norwegian IT industry. He has served on several boards.
Olav has 40 years background from the international pharma and life science industry. This includes 26 years as medical director for GSK in Norway, Sweden and Portugal. His experience covers consultancy to and non-ex directorship in listed and non-listed Biotech, Pharma and MedTech companies.
Chandan is part of the team behind the TDS technology. A former Senior Research Fellow and co-head of the Experimental Pathology Group at the William Harvey Research Institute, London, UK, Chandan has published more than 45 papers on angiogenesis, various animal models of disease and transdermal delivery of drugs.
Petter is an international executive with more than 25 years of experience from startups in Europe and the US. A strategic relationship builder has held CEO and other C-level positions in private and public international companies and is now focusing on technology and life science businesses from his base in Florida.
Steven is a graduate from BI Norwegian Business School in Oslo where he studied Economics and Management, and where he is planning to continue towards a Master in Sustainable Finance degree. He has previously studied medicine and is highly motivated to learn about the Pharmacology and Biotech industries, in which he wants to pursue his future career.
